Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Taiyeb M Khumri"'
Publikováno v:
Echo Research and Practice, Vol 4, Iss 2, Pp 17-19 (2017)
A 68-year-old man with a severe ischemic cardiomyopathy underwent left ventricular assist device (LVAD) implantation (Heart Mate II device) for destination therapy. He presented 49 months after LVAD implantation with worsening heart failure symptoms
Externí odkaz:
https://doaj.org/article/2f3f3600257c44ea91372a50a295ce10
Autor:
John J. Ryan, Michael Fong, Guillermo E. Umpierrez, Gregory D. Lewis, Sunit-Preet Chaudhry, Kavita Sharma, Chen H Chow, Manreet Kanwar, Yevgeniy Khariton, Mikhail Kosiborod, Taiyeb M. Khumri, Sadiya S. Khan, Michael E. Nassif, Sumant Lamba, Sanjiv J. Shah, Fengming Tang, Sheryl L. Windsor, Ali O. Malik, Barry A. Borlaug, Dalane W. Kitzman, Michael Pursley, Susan M Joseph, Robert Gordon, Lokesh Chandra, Barry S Clemson, Elias S. Siraj
Publikováno v:
Nature Medicine
Patients with heart failure and preserved ejection fraction (HFpEF) have a high burden of symptoms and functional limitations, and have a poor quality of life. By targeting cardiometabolic abmormalities, sodium glucose cotransporter 2 (SGLT2) inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192001f5e17fcb5cb43d8ff676249d7d
https://doi.org/10.1038/s41591-021-01536-x
https://doi.org/10.1038/s41591-021-01536-x
Autor:
Taiyeb M. Khumri, Brett W. Sperry, Deepthi Vodnala, Yasser Sammour, Christopher DeZorzi, Andrew Kao, Timothy J. Fendler, Mark P. Everley, Bethany A. Austin, Anthony Magalski, S.L. Lawhorn, Michael E. Nassif, A. Michael Borkon
Publikováno v:
Journal of Cardiac Failure. 27:812-815
Statins are recommended in heart transplant patients, but are sometimes poorly tolerated. Alternative agents are often considered including proprotein convertase subtilisin/kexin type-9 inhibitors (PCSK9i). We sought to investigate the use of PCSK9i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ea93d86e496de7890a61c72191b327
https://doi.org/10.1016/j.cardfail.2021.02.018
https://doi.org/10.1016/j.cardfail.2021.02.018
Autor:
Merrill Thomas, Melissa Magwire, Brett W. Sperry, Timothy J. Fendler, Michael E. Nassif, Taiyeb M. Khumri, Yasser Sammour, James H. O'Keefe, Mikhail Kosiborod
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:426-429
Type 2 diabetes mellitus (T2D) is a common comorbidity among patients who have undergone heart transplantation. Recently two classes of glucose-lowering medications (sodium-glucose cotransporter type-2 inhibitors [SGLT-2Is] and glucagon-like-peptide-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0997f9562b31c6a52bc3092e1e7819e2
https://doi.org/10.1016/j.healun.2021.02.012
https://doi.org/10.1016/j.healun.2021.02.012
Autor:
Brett W. Sperry, Anthony Magalski, Michael E. Nassif, Kevin F. Kennedy, Taiyeb M. Khumri, Timothy J. Fendler, Ahmed A. Harhash
Publikováno v:
The American Journal of Cardiology. 144:20-25
Cardiogenic shock (CS) is associated with high mortality and often requires involvement of a multidisciplinary provider team to deliver timely care. Care coordination is more difficult on weekends, which may lead to a delay in care. We sought to asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23698946283c59a700c049d05a93cbe5
https://doi.org/10.1016/j.amjcard.2020.12.061
https://doi.org/10.1016/j.amjcard.2020.12.061
Autor:
Michael E. Nassif, Andrew Kao, Brett W. Sperry, Bethany A. Austin, Keerthi T. Gondi, Anthony Magalski, S.L. Lawhorn, Mark P. Everley, Taiyeb M. Khumri, A. Michael Borkon, Timothy J. Fendler, Jodie Linard, Deepthi Vodnala
Publikováno v:
Clinical Transplantation. 35
Background Gene expression profiling (GEP) and donor-derived cell-free DNA (dd-cfDNA) are useful in acute rejection (AR) surveillance in orthotopic heart transplant (OHT) patients. We report a single-center experience of combined GEP and dd-cfDNA tes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::524a8a63d2b90bcd680da1b72d698a8e
https://doi.org/10.1111/ctr.14258
https://doi.org/10.1111/ctr.14258
Publikováno v:
Clinical Transplantation
The SARS‐CoV‐2 pandemic poses unique and unprecedented challenges to patients, providers, and healthcare systems. Coronavirus Disease 2019 (COVID‐19) appears to be high‐risk in patients with cardiovascular disease as well as those on immunosu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e0b1e067844b839e6d412c95264dbd
Autor:
Andrew Kao, D. Vodnala, Anthony Magalski, A.M. Borkon, Michael E. Nassif, Bethany A. Austin, Taiyeb M. Khumri, Timothy J. Fendler, Brett W. Sperry, Mark P. Everley, J. Linard, S.L. Lawhorn
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S253-S254
Purpose Gene expression profile (GEP) testing has a high negative predictive value for Methods dd-cfDNA was drawn beginning at 2 mos post transplant and GEP was drawn at 2 mos or 30 days post prednisone wean Results Between 2/11-10/4/19, 121 pts (54.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24c0a825c4b98d47c6bbfa2bd50ba95d
https://doi.org/10.1016/j.healun.2020.01.549
https://doi.org/10.1016/j.healun.2020.01.549
Autor:
Bethany A. Austin, Taiyeb M. Khumri, S.L. Lawhorn, Anthony Magalski, Mark P. Everley, Deepthi Vodnala, Michael E. Nassif, Yasser Sammour, Merrill Thomas, Timothy J. Fendler, Brett W. Sperry, Andrew Kao, Melissa Magwire, Mikhail Kosiborod
Publikováno v:
Journal of Cardiac Failure. 26:S26
Background Type 2 diabetes mellitus (T2D) is common in post-heart transplant patients. Commonly used T2D medications, especially insulin, can promote weight gain and are not associated with cardiovascular (CV) benefits. Glucagon-like Peptide-1 recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b6fdc2a1619e1e89dd1d6a559cf4fc9
https://doi.org/10.1016/j.cardfail.2020.09.081
https://doi.org/10.1016/j.cardfail.2020.09.081
Autor:
Rajiv Chhabra, Pallavi Surana, Devika Kapuria, Salman Khan, Shariq Shamim, Nabil Al-Khalisi, Sanjeev Aggarwal, Taiyeb M. Khumri, Christopher Koh
Publikováno v:
Heliyon
Heliyon, Vol 6, Iss 9, Pp e04695-(2020)
Heliyon, Vol 6, Iss 9, Pp e04695-(2020)
Background and aims Heart failure is one of the leading causes of morbidity and mortality in the United States. The advent of left ventricular assist devices (LVAD) has improved the survival and quality of life in patients with end stage heart failur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a79daffe6eb866cc2e6b749f7db78d
https://doi.org/10.1016/j.heliyon.2020.e04695
https://doi.org/10.1016/j.heliyon.2020.e04695